The main causes of death in patients with COVID-19

P Oboza1, N Ogarek, M Olszanecka-Glinianowicz

  • 1Students' Scientific Society at the Pathophysiology Unit, Pathophysiology Unit, Health Promotion and Obesity Management Unit, Department of Pathophysiology, Medical Faculty, The Medical University of Silesia, Katowice, Poland. pkocelak@sum.edu.pl.

Insights

The primary cause of COVID-19 deaths is multiple organ failure, driven by severe inflammation and genetic factors. Thrombotic microangiopathy, particularly in microcirculation, emerges as a dominant, fatal mechanism in COVID-19 mortality.

Area of Science:

  • * Pathology and Public Health
  • * Infectious Diseases and Epidemiology

Background:

  • * The COVID-19 pandemic has caused millions of deaths globally, with significant mortality reported in the United States, Brazil, and India.
  • * Understanding the precise mechanisms leading to fatal outcomes in COVID-19 is crucial for effective treatment and prevention strategies.

Purpose of the Study:

  • * To analyze available data on the causes of death attributed to COVID-19.
  • * To identify the primary pathological mechanisms underlying COVID-19 mortality.

Main Methods:

  • * Retrospective analysis of reported COVID-19 mortality data.
  • * Review of scientific literature on COVID-19 pathological mechanisms and contributing factors.

Main Results:

  • * Multiple organ failure is identified as the primary cause of death from COVID-19.
  • * Severe inflammatory response, potentially influenced by genetic predisposition, contributes significantly to organ failure.
  • * Systemic thrombotic microangiopathy and lung inflammation leading to hypoxia are key pathological processes, with thrombotic changes in microcirculation being the most dominant factor.

Conclusions:

  • * COVID-19 mortality is predominantly linked to multiple organ failure resulting from complex pathological pathways.
  • * Thrombotic microangiopathy and severe inflammation are critical determinants of fatal COVID-19 outcomes.
  • * Comorbidities may exacerbate thrombotic risks in COVID-19 patients, highlighting the multifaceted nature of the disease's lethality.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
19
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
294
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
320
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
241
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
400
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
265